Patents by Inventor Richard Alan Gibbs

Richard Alan Gibbs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt
    Patent number: 7304084
    Abstract: 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile substantially free of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile, and the anhydrous monoacetate salt thereof, are useful in the treatment of alpha-2 mediated disorders such as ocular hypertension.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: December 4, 2007
    Assignee: The Board of Regents of the University of Nebraska
    Inventors: Jared Lynn Randall, Richard Alan Gibbs, Gregory Kent Bosch, Michael David Curtis, Li Sun, Nicholas Nikolaides
  • Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
    Publication number: 20040167194
    Abstract: 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile substantially free of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile, and the anhydrous monoacetate salt thereof, are useful in the treatment of alpha-2 mediated disorders such as ocular hypertension.
    Type: Application
    Filed: March 12, 2003
    Publication date: August 26, 2004
    Inventors: Jared Lynn Randall, Richard Alan Gibbs, Gregory Kent Bosch, Michael David Curtis, Li Sun, Nicholas Nikolaides